In uncertain markets, controlling costs, boosting efficiency and increasing profitability all take ... resources to high-impact programs control costs and improve efficiency.

We expect modest improvements in operating profit margins over the next five years, driven by mix shift toward the higher-margin pharma division and cost controls across business lines.